Lanzostad

Lansoprazole, the active ingredient in Lanzostad, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is used to manage conditions such as gastro‑esophageal reflux disease, peptic ulcer disease, erosive esophagitis and Helicobacter pylori eradication regimens in adult patients.

GNH USA supplies Lanzostad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for bulk and packaged orders across multiple regions.

Lansoprazole acts on the gastric acid‑secretion pathway and is indicated for several acid‑related disorders.

- Gastro‑esophageal reflux disease (GERD): provides symptomatic relief by decreasing reflux‑related heartburn and regurgitation. - Peptic ulcer disease: promotes ulcer healing by maintaining a higher gastric pH. - Erosive esophagitis: facilitates mucosal recovery through sustained acid suppression. - Helicobacter pylori eradication regimens: enhances antibiotic efficacy when used as part of combination therapy.

Lansoprazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild, transient pain in the head. - Diarrhea: loose stools occurring during treatment. - Nausea: feeling of sickness or urge to vomit. - Abdominal pain: discomfort or cramps in the stomach area.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea with abdominal cramping. - Low magnesium levels: muscle weakness, irregular heartbeat, or seizures.

Before prescribing Lansoprazole, clinicians should consider several safety precautions.

- Assess renal function: adjust use in patients with severe impairment. - Monitor magnesium: prolonged therapy may cause hypomagnesemia. - Evaluate for infection risk: acid suppression can increase susceptibility to gastrointestinal infections. - Use cautiously in the elderly: higher incidence of bone fractures reported. - Avoid concomitant use with drugs that require gastric acidity for absorption unless medically necessary. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lansoprazole can affect the plasma concentrations of several co‑administered medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: markedly decreased antiviral exposure. - Methotrexate: increased toxicity risk due to reduced clearance.

Moderate Interactions (Monitor Closely): - Digoxin: modest increase in serum levels. - Phenytoin: decreased anticonvulsant concentrations. - Oral contraceptives: possible reduction in hormonal efficacy.